Atlas Trials

Trial to Examine the Effect of Two Doses of GRI-0621 in Patients With Chronic Liver Disease

Clinical trial NCT02949375 · TERMINATED

Trial details

NCT number
NCT02949375
Sponsor
GRI Bio Operations, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Liver Disease
Start date
2015-09-01
Primary completion
2018-11-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.